When assessing the differences, it was observed that in SCLC patients, RB1 was depicted with a higher number of different mutations and this gene was altered in a higher number of patients (in tumors), while in blood samples, RET, ATM, and ABL1 appeared altered only in the SCLC group. This evidence concerns the gene RB1 and small cell lung carcinoma.